Q2 2026 Holdings
Filed 2026-08-14 | 41 holdings | $2.2B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Aurinia Pharmaceuticals Inc(AUPH) | COM | 05156V102 | $221.4M | 13,044,106 | 10.1% |
| Spyre Therapeutics Inc(SYRE) | COM NEW | 00773J202 | $168.0M | 1,892,200 | 7.6% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $144.7M | 1,236,027 | 6.6% |
| Kiniksa Pharmaceuticals Intl(KNSA) | ORD SHS CL A | G52694109 | $144.5M | 2,259,889 | 6.6% |
| Celcuity Inc(CELC) | COM | 15102K100 | $137.5M | 1,314,594 | 6.2% |
| Corcept Therapeutics Inc(CORT) | COM | 218352102 | $130.4M | 1,500,000 | 5.9% |
| PTC Therapeutics Inc(PTCT) | COM | 69366J200 | $122.4M | 1,500,000 | 5.6% |
| Lakefront Biotherapeutics NV(GLPG) | SPON ADR | 36315X101 | $113.5M | 3,785,991 | 5.2% |
| Capricor Therapeutics Inc(CAPR) | COM NEW | 14070B309 | $98.7M | 4,099,900 | 4.5% |
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $98.7M | 1,568,266 | 4.5% |
| State STR Spdr S&P 500 ETF T(SPY) | TR UNIT | 78462F103 | $91.9M | 123,000 | 4.2% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $89.8M | 1,330,879 | 4.1% |
| Immunocore Hldgs PLC(IMCR) | ADS | 45258D105 | $84.1M | 2,649,368 | 3.8% |
| Compass Pathways PLC(CMPS) | SPONSORED ADS | 20451W101 | $70.8M | 5,000,000 | 3.2% |
| ANI Pharmaceuticals Inc(ANIP) | COM | 00182C103 | $58.6M | 707,500 | 2.7% |
| Biontech SE(BNTX) | SPONSORED ADS | 09075V102 | $43.7M | 470,000 | 2.0% |
| Compass Therapeutics Inc(CMPX) | COM | 20454B104 | $39.4M | 17,990,782 | 1.8% |
| Precigen Inc(PGEN) | COM | 74017N105 | $36.6M | 6,417,500 | 1.7% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $32.9M | 1,792,626 | 1.5% |
| Nuvectis Pharma Inc(NVCT) | COM | 67080T108 | $28.5M | 1,550,000 | 1.3% |
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $25.8M | 264,692 | 1.2% |
| Fulcrum Therapeutics Inc(FULC) | COM | 359616109 | $23.9M | 6,521,412 | 1.1% |
| Atea Pharmaceuticals Inc(AVIR) | COM | 04683R106 | $22.4M | 4,814,700 | 1.0% |
| Crescent Biopharma Inc.(CBIO) | COM | G2545C104 | $20.9M | 1,160,000 | 0.9% |
| Nano Dimension LTD(NNDM) | SPONSORD ADS NEW | 63008G203 | $20.7M | 14,292,813 | 0.9% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $19.5M | 500,000 | 0.9% |
| Nuvation BIO Inc(NUVB) | COM CL A | 67080N101 | $18.7M | 3,299,557 | 0.9% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $16.8M | 450,000 | 0.8% |
| Gossamer BIO Inc | NOTE 5.000% 6/0 | 38341PAA0 | $11.5M | $17,841,000 | 0.5% |
| Journey MED Corp(DERM) | COM | 48115J109 | $11.4M | 1,610,000 | 0.5% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $10.7M | 100,000 | 0.5% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $9.8M | 300,000 | 0.4% |
| Pliant Therapeutics Inc(PLRX) | COM | 729139105 | $7.0M | 6,141,261 | 0.3% |
| Boundless BIO Inc(BOLD) | COM | 10170A100 | $6.4M | 2,559,875 | 0.3% |
| PMV Pharmaceuticals Inc(PMVP) | COM | 69353Y103 | $5.7M | 4,245,085 | 0.3% |
| Moderna Inc(MRNA) | COM | 60770K107 | $3.5M | 50,000 | 0.2% |
| Wave Life Sciences LTD(WVE) | SHS | Y95308105 | $3.5M | 600,000 | 0.2% |
| Heron Therapeutics Inc(HRTX) | COM | 427746102 | $2.7M | 6,250,000 | 0.1% |
| Lenz Therapeutics Inc(LENZ) | COM | 52635N103 | $2.6M | 451,114 | 0.1% |
| Altimmune Inc(ALT) | COM NEW | 02155H200 | $2.0M | 666,022 | 0.1% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $342.0K | 100,000 | 0.0% |